Source link : https://www.newshealth.biz/health-news/how-many-ditch-glp-1-drugs-more-weekly-insulin-data-ozempic-for-alcohol-use/
At 12 months, 36.5% of people had discontinued their GLP-1 receptor agonist in a study of nearly 200,000 adults with obesity with or without type 2 diabetes. (JAMA Network Open) In a phase Ib trial, a once-weekly injection of the dual GLP-1/GIP receptor agonist CT-388 led to a mean placebo-adjusted weight loss of 18.8% over […]
Author : News Health
Publish date : 2024-05-28 14:39:56
Copyright for syndicated content belongs to the linked Source.
Categories